SCHEMBL27776940

SCHEMBL27776940

CC(=O)OC(C)Nc1cccc(Br)c1N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ ANPEP P15144 1/20 0.33
▸ CASP3 P42574 1/20 0.32
▸ CASP2 P42575 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ CASP8 Q14790 1/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TP53 P04637 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ XIAP P98170 1/20 0.31
▸ BIRC2 Q13490 1/20 0.31
▸ LMNA P02545 2/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28785699 0.78 TP53 (0.41) ALDH1A1RAB9AL3MBTL1HTTMEN1
SCHEMBL1654361 0.76 EGFR (0.36) ALDH1A1ANPEPL3MBTL1ATMGAA
SCHEMBL11701504 0.71 KDM4E (0.42) ALDH1A1RAB9AL3MBTL1ATMMEN1
SCHEMBL14764227 0.70 L3MBTL1 (0.50) ALDH1A1ANPEPRAB9AL3MBTL1HTT
SCHEMBL18496354 0.70 ALDH1A1 (0.36) ALDH1A1L3MBTL1TP53EGFR
SCHEMBL27776939 0.70 KDM4E (0.39) ALDH1A1L3MBTL1HTTMEN1KMT2A
SCHEMBL27617116 0.68 ALDH1A1 (0.40) ALDH1A1ATMMEN1KMT2ALMNA
SCHEMBL8644889 0.67 TDP1 (0.48) ALDH1A1RAB9AL3MBTL1HTTATM
SCHEMBL27791867 0.67 MAPK1 (0.47) ALDH1A1L3MBTL1KMT2AGAALMNA
SCHEMBL30205969 0.66 EGFR (0.39) ALDH1A1RAB9AL3MBTL1ATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101678020-B Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases NOVARTIS AG 2012-08-15 — — CN disclosed
CN-101678020-A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases NOVARTIS AG 2010-03-24 — — CN disclosed
Send feedback